← All Kestra Medical Technologies, LTD filings

Kestra Medical Technologies, LTD 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

14 Jul 2026

KMTS

10-K: Kestra Medical Technologies Reports Strong Revenue Growth

Kestra Medical Technologies, Ltd. announced a 59% increase in revenue for the fiscal year ended April 30, 2026, driven by a significant rise in patient adoption of its ASSURE WCD.

NASDAQ

17 Jul 2025

KMTS

Kestra Medical Technologies, LTD

10-K: Kestra Medical Technologies Reports Soaring FY2025 Revenue Amidst Continued Strategic Investments and Net Losses

Kestra Medical Technologies, a commercial-stage medical device company, announced a significant 115% surge in revenue for the fiscal year ended April 30, 2025, driven by strong adoption of its ASSURE WCD, despite reporting increased net losses as it continues to invest heavily in growth and infrastructure.